首页 > 市场调查报告书 > 製药

欧洲阿片类药物市场预测至 2030 年 - 区域分析 - 按产品、应用、给药途径和配销通路

市场调查报告书

商品编码

1637659

欧洲阿片类药物市场预测至 2030 年 - 区域分析 - 按产品、应用、给药途径和配销通路

Europe Opioids Market Forecast to 2030 - Regional Analysis - by Product, Application, Route of Administration, and Distribution Channel

出版日期: 2024年11月22日 | 出版商:

The Insight Partners | 英文 90 Pages | 订单完成后即时交付

价格

简介目录图表

2022年欧洲阿片类药物市值为45.5386亿美元，预计2030年将达到52.3772亿美元；预计2022年至2030年复合年增长率为1.8%。

慢性疼痛发生率激增推动欧洲阿片类药物市场

心血管疾病、癌症、肌肉骨骼疾病和神经血管疾病等慢性疾病会降低免疫力，严重影响人的健康。此外，许多患有这些病症的患者会经历慢性疼痛。上述疾病在成人和老年族群中最常见。然而，儿童中这些疾病的病例也明显增加。慢性疼痛在运动员、运动员和曾经受伤的人中也很常见。根据NCBI（即国家生物技术资讯中心）发表的一项研究，全世界有20%的成年人患有疼痛，并且每年有10%新诊断出患有慢性疼痛。虽然疼痛影响所有人群，无论性别、种族/民族、收入、年龄或地理位置如何，但疼痛在世界各地的分布并不均匀。处方阿片类药物，包括氢可酮、羟考酮和吗啡，是有效的止痛药物，用于治疗因受伤、手术以及癌症和关节炎等健康状况引起的疼痛。阿片类药物处方实践的增加可归因于保险报销计划，该计划激励阿片类药物而不是替代性疼痛治疗、鼓励更有效护理的成本结构以及将患者满意度与有效疼痛管理相结合的评估。因此，由于阿片类药物在疼痛管理方面的优势，对慢性病患者的需求不断上升。

欧洲阿片类药物市场概况

欧洲鸦片类药物市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。欧洲在欧洲阿片类药物市场中占据重要地位，预计在预测期内将经历强劲的市场成长。该地区的市场成长主要归因于引起慢性疼痛的疾病（如关节炎、腰痛和纤维肌痛）的盛行率上升以及治疗阿片类药物成瘾（如海洛因）的药物供应量激增。例如，美沙酮是欧洲使用最多的鸦片类激动剂，75% 的患者使用美沙酮进行鸦片类激动剂维持治疗。丁丙诺啡是该地区第二常用的鸦片类激动剂。然而，它是克罗埃西亚、塞浦路斯、捷克共和国、芬兰、法国和瑞典最常用的鸦片类药物维持治疗之一。可待因是塞浦路斯和德国使用的主要激动剂，而二乙酰吗啡则是比利时、丹麦、德国、荷兰、西班牙、英国和爱尔兰常用的激动剂。

欧洲阿片类药物市场收入及 2030 年预测（百万美元）

欧洲阿片类药物市场细分

欧洲阿片类药物市场按产品、应用、给药途径、配销通路和国家分类。

根据产品，欧洲鸦片类药物市场分为速释短效鸦片类药物和缓释长效型鸦片类药物。 2022年，速释短效鸦片类药物细分市场占据了更大的市场份额。芬等。缓释长效型鸦片类药物进一步细分为羟考酮、芬太尼、吗啡、美沙酮等。

从应用来看，欧洲鸦片类药物市场分为疼痛管理、麻醉、止泻、止咳、戒瘾等。 2022 年，疼痛管理领域占据最大的市场。

依给药途径，欧洲阿片类药物市场分为口服、注射和经皮贴片。 2022 年，口腔细分市场占据最大的市场份额。

按配销通路划分，欧洲阿片类药物市场分为医院药房和零售药房。 2022年，医院药局部门将占据更大的市场份额。

依国家/地区划分，欧洲阿片类药物市场分为英国、德国、法国、义大利、西班牙和欧洲其他地区。 2022 年，英国在欧洲阿片类药物市场份额中占据主导地位。

Endo International plc、Mallinckrodt Plc、Neuraxpharm Pharmaceuticals SL、Hikma Pharmaceuticals Plc、Rusan Pharma Ltd 和 Teva Pharmaceutical Industries Ltd 是欧洲阿片类药物市场上的一些领先公司。

Chronic diseases such as cardiovascular disease, cancer, musculoskeletal diseases, and neurovascular diseases critically affect a person's health by lowering immunity. Moreover, many patients suffering from these conditions experiences chronic pain. The diseases mentioned above are most common in adults and the geriatric population. Nevertheless, cases of these diseases are noticeably growing among children as well. Chronic pain is also common among sportspersons, athletes, and individuals living with past injuries. According to a study published in the NCBI (i.e., National Center for Biotechnology Information), 20% of adults suffer from pain worldwide, and 10% are newly diagnosed with chronic pain per year. While pain affects all populations, regardless of sex, race/ethnicity, income, age, or geography, it is not distributed equally across the world. Prescription opioids, including hydrocodone, oxycodone, and morphine, are potent pain-reducing medications that are used to treat pain caused by injuries, surgeries, and health conditions such as cancer and arthritis. Increased opioid prescribing practices can be attributed to the insurance reimbursement programs that incentivize opioids over alternative pain treatments, cost structures that encourage more efficient care, and evaluations that combine patient satisfaction with effective pain management. Therefore, owing to the advantage of opioids in pain management, the demand is rising among patients with chronic diseases.

Europe Opioids Market Overview

The Europe opioids market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the Europe opioids market and is expected to experience strong market growth during the forecast period. The market growth in the region is mainly attributed to the rising prevalence of diseases that cause chronic pain (such as arthritis, lower back pain, and fibromyalgia) and the surging availability of medications to treat addiction to opioid drugs (such as heroin). For instance, methadone is the most prescribed opioid agonist in Europe and is used in 75% of patients for opioid agonist maintenance treatment. Buprenorphine is the second most used opioid agonist in the region. However, it is one of the most often used opioid maintenance treatments in Croatia, Cyprus, the Czech Republic, Finland, France, and Sweden. Codeine is the primary agonist used in Cyprus and Germany, whereas diacetylmorphine is the one that is commonly used in Belgium, Denmark, Germany, the Netherlands, Spain, the UK, and Ireland.

Europe Opioids Market Revenue and Forecast to 2030 (US$ Million)

Europe Opioids Market Segmentation

The Europe opioids market is categorized into product, application, route of administration, distribution channel, and country.

Based on product, the Europe opioids market is segmented immediate release short acting opioid and extended release long acting opioid. The immediate release short acting opioid segment held a larger market share in 2022. The immediate release short acting opioid is further sub segmented into oxycodone, hydrocodone, tramadol, codeine, propoxyphene, and others. The extended release long acting opioid is further sub segmented into oxycodone, fentanyl, morphine, methadone, and others.

In terms of application, the Europe opioids market is categorized into pain management, anesthesia, diarrhea suppression, cough suppression, de-addiction, and others. The pain management segment held the largest market share in 2022.

By route of administration, the Europe opioids market is segmented into oral, injectable, and transdermal patch. The oral segment held the largest market share in 2022.

By distribution channel, the Europe opioids market is bifurcated into hospital pharmacies and retail pharmacies. The hospital pharmacies segment held a larger market share in 2022.

By country, the Europe opioids market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The UK dominated the Europe opioids market share in 2022.

Endo International plc, Mallinckrodt Plc, Neuraxpharm Pharmaceuticals SL, Hikma Pharmaceuticals Plc, Rusan Pharma Ltd, and Teva Pharmaceutical Industries Ltd are some of the leading companies operating in the Europe opioids market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Opioids Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Surging Chronic Pain Incidence
- 4.1.2 Increasing Geriatric Population
4.2 Market Restraints
- 4.2.1 Increasing Drug Abuse
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives by Market Players
4.4 Impact of Drivers and Restraints:

5. Opioids Market - Europe Analysis

5.1 Europe Opioids Market Overview
5.2 Europe Opioids Market Revenue (US$ Million), 2020-2030
5.3 Europe Opioids Market Forecast Analysis

6. Europe Opioids Market Analysis - by Product

6.1 Immediate Release Short Acting Opioid
- 6.1.1 Overview
- 6.1.2 Immediate Release Short Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.1.2.1 Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
6.2 Extended Release Long-Acting Opioid
- 6.2.1 Overview
- 6.2.2 Extended Release Long-Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.2.2.1 Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

7. Europe Opioids Market Analysis - by Application

7.1 Pain Management
- 7.1.1 Overview
- 7.1.2 Pain Management: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Anesthesia
- 7.2.1 Overview
- 7.2.2 Anesthesia: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Diarrhea Suppression
- 7.3.1 Overview
- 7.3.2 Diarrhea Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cough Suppression
- 7.4.1 Overview
- 7.4.2 Cough Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.5 De-Addiction
- 7.5.1 Overview
- 7.5.2 De-Addiction: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Opioids Market Analysis - by Route of Administration

8.1 Oral
- 8.1.1 Overview
- 8.1.2 Oral: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Injectable
- 8.2.1 Overview
- 8.2.2 Injectable: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Transdermal Patch
- 8.3.1 Overview
- 8.3.2 Transdermal Patch: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Opioids Market Analysis - by Distribution Channel

9.1 Hospital Pharmacies
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Retail Pharmacies
- 9.2.1 Overview
- 9.2.2 Retail Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Opioids Market - Country Analysis

10.1 Europe
- 10.1.1 Europe: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
  - 10.1.1.1 Europe: Opioids Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 United Kingdom: Europe Opioids Market Breakdown, by Product
    - 10.1.1.2.2 United Kingdom: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
    - 10.1.1.2.3 United Kingdom: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
    - 10.1.1.2.4 United Kingdom: Europe Opioids Market Breakdown, by Application
    - 10.1.1.2.5 United Kingdom: Europe Opioids Market Breakdown, by Route of Administration
    - 10.1.1.2.6 United Kingdom: Europe Opioids Market Breakdown, by Distribution Channel
  - 10.1.1.3 Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Germany: Europe Opioids Market Breakdown, by Product
    - 10.1.1.3.2 Germany: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
    - 10.1.1.3.3 Germany: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
    - 10.1.1.3.4 Germany: Europe Opioids Market Breakdown, by Application
    - 10.1.1.3.5 Germany: Europe Opioids Market Breakdown, by Route of Administration
    - 10.1.1.3.6 Germany: Europe Opioids Market Breakdown, by Distribution Channel
  - 10.1.1.4 France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.1 France: Europe Opioids Market Breakdown, by Product
    - 10.1.1.4.2 France: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
    - 10.1.1.4.3 France: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
    - 10.1.1.4.4 France: Europe Opioids Market Breakdown, by Application
    - 10.1.1.4.5 France: Europe Opioids Market Breakdown, by Route of Administration
    - 10.1.1.4.6 France: Europe Opioids Market Breakdown, by Distribution Channel
  - 10.1.1.5 Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.1 Italy: Europe Opioids Market Breakdown, by Product
    - 10.1.1.5.2 Italy: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
    - 10.1.1.5.3 Italy: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
    - 10.1.1.5.4 Italy: Europe Opioids Market Breakdown, by Application
    - 10.1.1.5.5 Italy: Europe Opioids Market Breakdown, by Route of Administration
    - 10.1.1.5.6 Italy: Europe Opioids Market Breakdown, by Distribution Channel
  - 10.1.1.6 Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.1 Spain: Europe Opioids Market Breakdown, by Product
    - 10.1.1.6.2 Spain: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
    - 10.1.1.6.3 Spain: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
    - 10.1.1.6.4 Spain: Europe Opioids Market Breakdown, by Application
    - 10.1.1.6.5 Spain: Europe Opioids Market Breakdown, by Route of Administration
    - 10.1.1.6.6 Spain: Europe Opioids Market Breakdown, by Distribution Channel
  - 10.1.1.7 Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.7.1 Rest of Europe: Opioids Market Breakdown, by Product
    - 10.1.1.7.2 Rest of Europe: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
    - 10.1.1.7.3 Rest of Europe: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
    - 10.1.1.7.4 Rest of Europe: Opioids Market Breakdown, by Application
    - 10.1.1.7.5 Rest of Europe: Opioids Market Breakdown, by Route of Administration
    - 10.1.1.7.6 Rest of Europe: Opioids Market Breakdown, by Distribution Channel

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Opioids Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Endo International plc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Mallinckrodt Plc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Neuraxpharm Pharmaceuticals SL
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Hikma Pharmaceuticals Plc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Rusan Pharma Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Teva Pharmaceutical Industries Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Europe Opioids Market Segmentation
Table 2. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 5. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 6. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 7. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 8. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 9. Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 10. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 11. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 12. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 13. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 14. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 15. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 16. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 17. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 18. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 19. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 20. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 21. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 22. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 23. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 24. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 25. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 26. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 27. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 28. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 29. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 30. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 31. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 32. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 33. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 34. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 35. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 36. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 37. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 38. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 39. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 40. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 41. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 42. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 43. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 44. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 45. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 46. Recent Organic Growth Strategies in Opioids Market
Table 47. Recent Inorganic Growth Strategies in the Opioids Market
Table 48. Glossary of Terms, Opioids Market

List Of Figures

Figure 1. Europe Opioids Market Segmentation, by Country
Figure 2. Europe Opioids Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Opioids Market Revenue (US$ Million), 2020-2030
Figure 5. Europe Opioids Market Share (%) - by Product (2022 and 2030)
Figure 6. Immediate Release Short Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Extended Release Long-Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Europe Opioids Market Share (%) - by Application (2022 and 2030)
Figure 9. Pain Management: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Anesthesia: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Diarrhea Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Cough Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. De-Addiction: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Europe Opioids Market Share (%) - by Route of Administration (2022 and 2030)
Figure 16. Oral: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Injectable: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Transdermal Patch: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 20. Hospital Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Retail Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Europe: Opioids Market Breakdown, by Key Countries - Revenue (2022) (US$ Million)
Figure 23. Europe: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Growth Strategies in Opioids Market